Department of Public Health Sciences, School of Public Health, University of Alberta, 2-040G Li Ka Shing Center for Health Research Innovation, 8602 112 Street, Edmonton, AB, Canada, T6G 2E1.
Diabetologia. 2014 Apr;57(4):690-8. doi: 10.1007/s00125-013-3158-8. Epub 2014 Feb 6.
AIMS/HYPOTHESIS: The aim of this work was to compare the incidence of illness attributable to influenza in working-age adults (age <65 years) with and without diabetes.
We performed a cohort study using administrative data from Manitoba, Canada, between 2000 and 2008. All working-age adults with diabetes were identified and matched with up to two non-diabetic controls. We analysed the rates of influenza-like illness physician visits and hospitalisations, pneumonia and influenza hospitalisations, and all-cause hospitalisations. Multivariable regressions were used to estimate the influenza-attributable rate of each outcome.
We included 745,777 person-years of follow-up among 166,715 subjects. The median age was 50-51 years and 48-49% were women; adults with diabetes had more comorbidities and were more likely to be vaccinated for influenza than those without diabetes. Compared with similar adults without diabetes, those with diabetes had a 6% greater (RR 1.06, 95% CI 1.02, 1.10; absolute risk difference 6 per 1,000 adults per year) increase in all-cause hospitalisations associated with influenza, representing a total of 54 additional hospitalisations. There were no differences in the influenza-attributable rates of influenza-like illness (p = 0.06) or pneumonia and influenza (p = 0.11).
CONCLUSIONS/INTERPRETATION: Guidelines calling for influenza vaccinations in diabetic, in addition to elderly, adults implicitly single out working-age adults with diabetes. The evidence supporting such guidelines has hitherto been scant. We found that working-age adults with diabetes appear more susceptible to serious influenza-attributable illness. These findings represent the strongest available evidence for targeting diabetes as an indication for influenza vaccination, irrespective of age.
目的/假设:本研究旨在比较有和无糖尿病的工作年龄成年人(<65 岁)因流感而患病的发生率。
我们使用了来自加拿大马尼托巴省 2000 年至 2008 年的行政数据进行了一项队列研究。确定了所有患有糖尿病的工作年龄成年人,并将他们与至多两名非糖尿病对照者相匹配。我们分析了流感样疾病医生就诊和住院、肺炎和流感住院以及全因住院的发生率。采用多变量回归估计每个结局的流感归因率。
我们纳入了 166715 名受试者的 745777 人年随访。中位年龄为 50-51 岁,48-49%为女性;与无糖尿病者相比,糖尿病患者的合并症更多,且更有可能接种流感疫苗。与相似的无糖尿病成年人相比,糖尿病患者的全因住院与流感相关的住院率增加了 6%(RR 1.06,95%CI 1.02,1.10;绝对风险差异每年每 1000 名成年人增加 6 例),总计增加了 54 例额外住院。流感样疾病(p=0.06)或肺炎和流感(p=0.11)的流感归因率无差异。
结论/解释:呼吁为糖尿病以及老年成年人接种流感疫苗的指南,明确将工作年龄的糖尿病成年人单独挑出。支持此类指南的证据迄今一直很少。我们发现,有糖尿病的工作年龄成年人似乎更容易受到严重的流感相关疾病的影响。这些发现代表了针对糖尿病作为流感疫苗接种指征的最强有力的现有证据,而不论年龄大小。